Lunit

LunitLunit
Lunit

Lunit

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

DR 632013Active370Seoul, South Korea
Rate

About

Lunit is a medical AI company that develops AI-powered solutions for cancer diagnostics and therapeutics. Their platform analyzes medical images such as X-rays and mammograms to aid in earlier and more accurate cancer detection, as well as biomarker analysis for treatment guidance. Lunit's solutions are used in over 10,000 healthcare facilities in more than 65 countries.
HEADCOUNT
370
DOMAIN RATING
63
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Lunit do?

Lunit is a medical AI company that develops AI-powered solutions for cancer diagnostics and therapeutics. Their platform analyzes medical images such as X-rays and mammograms to aid in earlier and more accurate cancer detection, as well as biomarker analysis for treatment guidance. Lunit's solutions are used in over 10,000 healthcare facilities in more than 65 countries.

How much funding has Lunit raised?

Lunit has raised a total of $1.1B in funding. The most recent round on record is Rights Offering.

Where is Lunit headquartered?

Lunit is headquartered in Seoul, South Korea.

When was Lunit founded?

Lunit was founded in 2013.

What industry does Lunit operate in?

Lunit operates in HealthTech, MedTech, AI-Driven Protein Design, Biotech, Drug Discovery, Clinical Trials.

How many employees does Lunit have?

Lunit has approximately 370 people on record.

What is Lunit's revenue?

StartupHub estimates Lunit's annual revenue at $100.8M (range $53.7M to $164.5M, 64% confidence), based on comparable companies in the sector.

What is Lunit's valuation?

StartupHub estimates Lunit's effective valuation at $4.4B (range $2.8B to $6.7B, 22% confidence), based on comparable companies in the sector.